Clinical Trials in Arizona

Showing 9901-9920 of 16,770 trials

A Study of OMP-313M32 in Subjects With Locally Advanced or Metastatic Solid Tumors

NCT03119428

The purpose of this study is to evaluate the safety and tolerability of OMP-31M32 as a single agent or in combination with nivolumab. OMP-313M32 is an experimental anti-TIGIT antibody that was developed to block TIGIT from binding PVR allowing the body's T-cells to destroy cancer cells.

Locally Advanced CancerMetastatic Cancer

OncoMed Pharmaceuticals, Inc.33 participantsStarted May 2017

Scottsdale, Arizona, United States • Durham, North Carolina, United States • Oklahoma City, Oklahoma, United States +2 more locations

COMPLETEDPhase 131 miles

Study of TTC-352 in Patients With Metastatic Breast Cancer Progressing on Endocrine Therapy

NCT03201913

Phase1 study of TTC 352 for treatment of metastatic ER+ breast cancer.

Metastatic ER+ Breast Cancer

TTC Oncology, LLC15 participantsStarted Dec 2017

Scottsdale, Arizona, United States • Saint Paul, Minnesota, United States • Sioux Falls, South Dakota, United States +1 more locations

TERMINATEDPhase 335 miles

Efficacy and Safety of Intravenous Neridronic Acid in Complex Regional Pain Syndrome (CRPS)

NCT03560986

The aim of this trial was to investigate the efficacy and safety of intravenous neridronic acid in subjects with Complex Regional Pain Syndrome (CRPS). The trial consisted of an Enrollment Period lasting up to 60 days, Treatment Period A consisting of 4 infusions (neridronic acid 100 mg or placebo) over 10 days, and a Follow-up Period 1 until Week 26. At Week 26, participants meeting the pre-specified criteria entered the open-label Treatment Period B with 4 additional infusions (neridronic acid) over 10 days and follow-up visits until Week 52. Participants not meeting the pre-specified criteria to continue into Treatment Period B continued in Follow-up Period 2 until Week 52.

Complex Regional Pain Syndrome (CRPS)

Grünenthal GmbH267 participantsStarted May 2018

Cottonwood, Arizona, United States • Tempe, Arizona, United States • Tucson, Arizona, United States +68 more locations

A Study of OMP-313M32 in Subjects With Locally Advanced or Metastatic Solid Tumors

Study of TTC-352 in Patients With Metastatic Breast Cancer Progressing on Endocrine Therapy

Efficacy and Safety of Intravenous Neridronic Acid in Complex Regional Pain Syndrome (CRPS)

Find Trials by Condition in Arizona

Safety and Efficacy of a Lysophosphatidic Acid Receptor Antagonist in Idiopathic Pulmonary Fibrosis

PRIMEx - A Study of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH)

Efficacy and Safety of Intravenous Neridronic Acid in CRPS

A Phase 3 STudy of CaPRe in LOwering Very hiGh TriglYcerides (TRILOGY 2)

Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancer

Lorcaserin in the Treatment of Cocaine Use Disorder

Blood Sample Collection to Evaluate Biomarkers for Hepatocellular Carcinoma

A Study to Assess the Efficacy and Safety of Abatacept in Adults With Active Primary Sjögrens Syndrome

Bortezomib, Ifosfamide, Carboplatin, and Etoposide, With or Without Rituximab, in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin Lymphoma

Open-label Trial of SUBA™-Itraconazole (SUBA-Cap) in Subjects With Basal Cell Carcinoma Nevus Syndrome (BCCNS)

Pazopanib Paediatric Phase II Trial Children's Oncology Group (COG) in Solid Tumors

A Study of OMP-305B83 in Subjects With Metastatic Colorectal Cancer

Study of the Safety, Pharmacodynamics, Efficacy, and PK of TIMP-GLIA in Subjects With Celiac Disease

Study of MLN2480 in Participants With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Participants With Metastatic Melanoma

A Rollover Safety Study of Lumacaftor/Ivacaftor in Subjects Aged 2 Years and Older With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation

Self-management to Improve Function Following Amputation

A Phase Ib/IIb, Open-label, Multi-center, Study of Oral Panobinostat Administered With 5-Azacitidine (in Adult Patients With Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myeloid Leukemia (AML).